Boston-based Dana-Farber Cancer Institute has appointed Andrew Lane, MD, PhD, as chief of the division of hematologic neoplasia.
The cancer institute announced Dr. Lane’s appointment in a May 24 LinkedIn post.
Dr. Lane joined Dana-Farber in 2008 and has served as associate division chief since 2024, the announcement said.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.